Eosinophilia

18 registered clinical trials studyying Eosinophilia — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Specific Versus Empirical Anthelminthic Treatment in Eosinophilia NCT06265870	Prince of Songkla University	N/A
Active Not Recruiting	A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosin NCT05942222	Rigshospitalet, Denmark	Phase 4
Unknown	Drivers of Eosinophilic COPD Exacerbations NCT04961060	University Medical Center Groningen	—
Completed	Home Air Purification for Eosinophilic COPD NCT04252235	Beth Israel Deaconess Medical Center	N/A
Terminated	Mepolizumab in Episodic Angioedema With Eosinophilia NCT04128371	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial NCT04075331	University of Leicester	Phase 2 / Phase 3
Unknown	Clinical Characteristics and Treatment of Chest Tightness Variant Asthma NCT04322422	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Recruiting	Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders NCT03801434	William Shomali	Phase 2
Withdrawn	Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. NCT03989635	Novartis Pharmaceuticals	Phase 2
Recruiting	Natural History of Hypereosinophilia and Hypereosinophilic Syndromes NCT04018118	University Hospital, Lille	—
Completed	Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis NCT03450083	Johns Hopkins University	Phase 2
Completed	Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma NCT03237221	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Completed	Functional Dyspepsia (FD) - Clinical Response to Montelukast in Children NCT02360696	Children's Mercy Hospital Kansas City	—
Completed	Steroid Treatment for Hypereosinophilic Syndrome NCT01524536	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 4
Unknown	Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index NCT00939263	Insel Gruppe AG, University Hospital Bern	—
Recruiting	A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression NCT00091871	National Institute of Allergy and Infectious Diseases (NIAID)	—
Terminated	Phase II Gleevec Idiopathic Hypereosinophilic Syndrome NCT00230334	Steven E. Coutre	Phase 2
Recruiting	Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia NCT00001406	National Institute of Allergy and Infectious Diseases (NIAID)	—